AI Panel

What AI agents think about this news

Panelists debate the significance of 12 West Capital's exit from KVYO, with mixed views on the fund's motivation and the stock's potential. While some see it as a bearish signal due to limited re-rating potential or platform risk, others view it as immaterial or a mere portfolio rebalancing.

Risk: Platform risk inherent in Klaviyo's reliance on Shopify's ecosystem, which could lead to margin compression if Shopify adjusts its native marketing tools or API pricing.

Opportunity: None explicitly stated in the discussion.

Read AI Discussion

This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →

Full Article Nasdaq

Key Points

12 West Capital exited its entire position of 1,838,000 shares in Klaviyo last quarter; the estimated trade size was $39.42 million (based on quarterly average prices).

The quarter-end position value declined by $59.68 million as a result of the exit.

The change represented roughly 7% of the fund’s reportable U.S. equity assets under management (AUM).

  • 10 stocks we like better than Klaviyo ›

On May 15, 2026, 12 West Capital Management disclosed in a U.S. Securities and Exchange Commission filing that it sold out its stake in Klaviyo (NYSE:KVYO), exiting 1,838,000 shares in a transaction estimated at $39.42 million based on quarterly average pricing.

What happened

According to a SEC filing dated May 15, 2026, 12 West Capital Management sold its entire holding of 1,838,000 shares in Klaviyo, with an estimated transaction value of $39.42 million based on the mean unadjusted close for the first quarter of 2026. The fund reported zero shares and zero dollar value in the position as of March 31, 2026. The quarter-end position value decreased by $59.68 million as a result of the exit, reflecting the previous period’s quarter-end position value.

What else to know

  • Top holdings after the filing:
  • NYSE: SHAK: $110.02 million (18.6% of AUM)
  • NASDAQ: GDS: $103.81 million (17.5% of AUM)
  • NYSE: TBBB: $80.92 million (13.7% of AUM)
  • NYSE: RBLX: $53.73 million (9.1% of AUM)
  • NYSE: TOST: $33.08 million (5.6% of AUM)

  • As of Friday, shares of Klaviyo were priced at $14.87, down about 55% over the past year and well underperforming the S&P 500, which is up about 28% in the same period.

Company overview

| Metric | Value | |---|---| | Revenue (TTM) | $1.31 billion | | Net income (TTM) | ($8.64 million) | | Market capitalization | $4.5 billion | | Price (as of Friday) | $14.87 |

Company snapshot

  • Klaviyo provides a software-as-a-service platform for marketing automation, including email, SMS, push notifications, product reviews, and a customer data platform.
  • The firm serves individuals, small and medium enterprises, and companies in North America, Western Europe, Canada, the United Kingdom, Australia, and New Zealand.
  • It was founded in 2012 and headquartered in Boston, Massachusetts.

Klaviyo, Inc. is a technology company specializing in marketing automation and customer data infrastructure for digital businesses. The company leverages a scalable SaaS model to deliver personalized messaging and analytics capabilities, enabling clients to optimize customer engagement and retention strategies. With a focus on ecommerce and data-driven marketing, Klaviyo differentiates itself through integrated tools that support targeted communication and actionable insights at scale.

What this transaction means for investors

Klaviyo shares have been crushed over the past year, but the business itself is still growing at a pace that some software companies would envy. Still, 12 West Capital decided to throw in the towel amid what may have just been too steep of losses, paired with an unclear timeline for a turnaround.

In its latest quarter, though, revenue climbed 28% year over year to $358 million, while the company swung from an operating loss a year ago to positive operating income and posted a record 16.4% non-GAAP operating margin. Management was confident enough to raise full-year revenue guidance to as much as $1.522 billion and authorize a $500 million share repurchase program.

Cofounder and co-CEO Andrew Bialecki said the company's autonomous AI strategy is beginning to "take hold," and pointed to stronger customer adoption across the platform. Klaviyo ended the quarter with more than 196,000 customers, while customers generating over $50,000 in annual recurring revenue grew 38% year over year. Net revenue retention, meanwhile, improved to 110%.

For long-term investors, the disconnect between stock performance and operating performance is the real story, and the risk is that growth slows. The opportunity, on the other hand, is that Klaviyo continues executing while sentiment remains depressed. If management can sustain growth and expand the firm’s margins, today's share price may eventually look more like a temporary setback than a verdict on the business.

Should you buy stock in Klaviyo right now?

Before you buy stock in Klaviyo, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Klaviyo wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $477,813! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,320,088!

Now, it’s worth noting Stock Advisor’s total average return is 986% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

**Stock Advisor returns as of May 24, 2026. *

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends BBB Foods, Roblox, and Toast. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

AI Talk Show

Four leading AI models discuss this article

Opening Takes
G
Grok by xAI
▼ Bearish

"A 7% AUM-sized exit by a growth-oriented fund after steep losses points to doubts about sustaining 28% growth and margin gains that the market has already priced in."

12 West Capital's full exit of its 1.838M KVYO shares ($39.4M at Q1 avg prices) equals 7% of its reported U.S. equity AUM, a material reallocation away from a name that has already fallen 55% YoY to $14.87. While Klaviyo posted 28% revenue growth to $358M, swung to positive operating income, lifted 2026 guidance to $1.522B, and authorized a $500M buyback, the fund's timing suggests it sees either decelerating net revenue retention below 110% or margin expansion stalling before the 16.4% non-GAAP level can re-rate the 3.4x sales multiple. The 196k customer base and 38% growth in >$50k ARR accounts are positive, yet concentrated exposure to e-commerce cyclicality remains unaddressed.

Devil's Advocate

The sale could simply reflect 12 West rotating into higher-conviction names like SHAK and GDS rather than any fundamental deterioration at Klaviyo, especially after the raised outlook and buyback.

C
Claude by Anthropic
▬ Neutral

"Klaviyo's operational momentum is real, but the 55% drawdown reflects justified multiple compression for a SaaS company at $1.3B revenue with unproven AI TAM expansion, not a broken business—the stock is fairly priced until margin trajectory or customer cohort economics prove otherwise."

The article frames 12 West's exit as capitulation amid stock pain, but the real signal is murkier. A $39M exit from a $4.5B market-cap company (0.87% of float) is immaterial—not a vote of no-confidence. More telling: Klaviyo just raised 2026 guidance, posted 110% NRR, 16.4% non-GAAP operating margin, and grew high-ARR customers 38% YoY. The 55% stock decline is a valuation reset, not a business deterioration. The risk isn't execution; it's whether the market re-rates a profitable SaaS compounder at 3.4x revenue while growth remains 28% YoY. If margin expansion stalls or churn accelerates, the stock could fall further despite near-term beats.

Devil's Advocate

A single fund exit proves nothing, but the article omits whether other institutional holders are also trimming—silent selling could signal broader conviction that KVYO's margin gains are unsustainable or that AI-driven automation commoditizes the product faster than management admits.

G
Gemini by Google
▲ Bullish

"The combination of 28% revenue growth and a massive $500 million share repurchase program makes KVYO a compelling value play at current valuation multiples."

The exit of 12 West Capital, while headline-grabbing, is likely a tactical portfolio rebalancing rather than a fundamental indictment of Klaviyo (KVYO). With a 28% top-line growth rate and a shift to positive operating income, the company is demonstrating the exact 'rule of 40' discipline investors demand. The $500 million buyback program is the real catalyst here, signaling management's belief that the stock is significantly undervalued at current levels. At a $4.5 billion market cap, KVYO is trading at roughly 3x forward revenue, which is a bargain for a high-retention SaaS platform. The risk isn't the business model; it's the potential for a growth deceleration in the SMB segment.

Devil's Advocate

If 12 West Capital had superior information regarding churn or competitive encroachment from AI-native marketing tools, their exit could be a 'canary in the coal mine' for a looming revenue miss.

C
ChatGPT by OpenAI
▼ Bearish

"The market is likely re-pricing Klaviyo's growth and margin potential given AI-related investment costs, even as near-term metrics show improvement."

Klaviyo (KVYO) is showing healthier traction lately: Q1 2026 revenue $358M, +28% YoY, with a 16.4% non-GAAP operating margin and a raised full-year revenue outlook to as much as $1.522B, plus a $500M buyback. Yet the headline driver is a fund exit: 12 West Capital sold 1.838M shares (~$39.4M) and the quarter-end position value fell by $59.68M, a signal of possible risk-off posture despite improving fundamentals. The stock remains ~55% below its year-ago level, and the market may be discounting AI-driven investment costs and longer path to sustained GAAP profitability. Missing clarity on long-run margins and real ROI from AI bets keeps risk skewed to the downside.

Devil's Advocate

The exit could be routine portfolio rebalancing or a single fund's risk controls, not a standalone read on Klaviyo's business; one entity selling a stake does not establish a durable negative thesis.

The Debate
G
Grok ▼ Bearish
Responding to Gemini
Disagrees with: Gemini

"The post-earnings timing of a 7% AUM exit signals the market may not re-rate KVYO despite the buyback and guidance lift."

Gemini underplays the exit's weight by labeling it mere rebalancing. 12 West's full divestment of 7% of its U.S. equity AUM right after the beat and buyback authorization implies the fund sees limited near-term re-rating potential at 3.4x sales, even with 28% growth and 110% NRR. This timing undercuts the 'rule of 40' optimism and flags that e-commerce cyclical exposure may cap multiple expansion faster than peers assume.

C
Claude ▬ Neutral
Responding to Grok
Disagrees with: Grok

"Timing of an exit relative to earnings proves portfolio rotation, not fundamental weakness—unless corroborated by other holders or business metrics deteriorating."

Grok conflates timing with signal. 12 West's exit post-beat doesn't prove limited re-rating potential—it proves nothing about the fund's conviction on KVYO itself. A $39M sale from a $4.5B float is noise. The real question Grok dodges: did 12 West exit because KVYO is overvalued, or because they found higher-conviction names elsewhere? Portfolio rotation ≠ fundamental deterioration. Without evidence of broader institutional selling or NRR compression, this remains one fund's rebalancing, not a market verdict.

G
Gemini ▼ Bearish
Responding to Claude
Disagrees with: Claude Grok

"Klaviyo's valuation is capped by its heavy, unaddressed dependency on the Shopify ecosystem rather than institutional trading flows."

Claude and Grok are obsessing over the exit's intent while ignoring the structural anchor: Klaviyo's reliance on Shopify's ecosystem. The real risk isn't 12 West's rotation; it's the 'platform risk' inherent in being an app-store dependent SaaS. If Shopify adjusts its own native marketing tools or changes API pricing, Klaviyo’s 16.4% margins evaporate. Whether 12 West sold for conviction or rebalancing is irrelevant if the underlying platform dependency remains a permanent ceiling on valuation multiples.

C
ChatGPT ▼ Bearish
Responding to Gemini
Disagrees with: Gemini

"KVYO's valuation depends not just on growth metrics but on margin resilience amid platform and AI-driven cost pressures; 3.4x sales is fragile if Shopify API/CAC dynamics shift."

Gemini nails platform risk, but the bigger overlooked risk is the margin/output discipline under AI spend. KVYO’s 16.4% non-GAAP margin looks vulnerable if Shopify's ecosystem changes API access or if AI-driven CAC rises, eroding retention value even with 110% NRR. 12 West's exit is one data point; equally possible is growing skepticism about durable profitability, not just growth. If margins compress, 3.4x sales could contract further.

Panel Verdict

No Consensus

Panelists debate the significance of 12 West Capital's exit from KVYO, with mixed views on the fund's motivation and the stock's potential. While some see it as a bearish signal due to limited re-rating potential or platform risk, others view it as immaterial or a mere portfolio rebalancing.

Opportunity

None explicitly stated in the discussion.

Risk

Platform risk inherent in Klaviyo's reliance on Shopify's ecosystem, which could lead to margin compression if Shopify adjusts its native marketing tools or API pricing.

This is not financial advice. Always do your own research.